Saxagliptin (trade name: Onglyza) is approved for adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed combination with metformin is available under ...
Oct 11, 2016
0
0
In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing ...
Sep 19, 2016
0
0
The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years even as cardiovascular disease has become the number one cause of death world-wide, according ...
Aug 29, 2016
0
0
The world's most commonly used Type 2 diabetes drug, Metformin, may be 'repurposed' to treat non-diabetic conditions according to researchers from the University of Dundee.
Aug 22, 2016
0
5
Although the recently FDA approved cholesterol-lowering drugs, PCSK9 inhibitors, could substantially reduce heart attacks, strokes, and cardiovascular deaths, they would not be cost-effective for use in patients with heterozygous ...
Aug 16, 2016
0
1
(HealthDay)—The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says.
Jul 28, 2016
0
5
Among nearly 120,000 adults with type 2 diabetes, there were no significant differences in the associations between any of 9 available classes of glucose-lowering drugs (alone or in combination) and the risk of cardiovascular ...
Jul 19, 2016
0
0
According to a new study published in the International Journal of Epidemiology this week, genetic research in large-scale prospective biobank studies can significantly improve the drug development pipeline and reduce costs.
Jun 15, 2016
0
3
Postmenopausal women with newly diagnosed diabetes have a significantly increased risk of atherosclerotic cardiovascular disease whether or not they take statin drugs, according to the results of a new study led by researchers ...
May 18, 2016
0
7
Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with average cholesterol and blood pressure levels who were considered to be at intermediate risk for heart disease, while the ...
Apr 4, 2016
0
7
